Literature DB >> 14560406

Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty.

Carl Deirmengian1, Jordan Greenbaum, Paul A Lotke, Robert E Booth, Jess H Lonner.   

Abstract

The purpose of this study was to review our experience in treating acute gram-positive infections after total knee arthroplasty with debridement, component retention, and intravenous antibiotics. Thirty-one total knee arthroplasties with acute gram-positive infections, seen at our institution over a 10-year period, were treated with open debridement and component retention. Eleven (35%) of 31 patients successfully retained their components at most recent follow-up, without ongoing infection (mean, 4 years; range, 2-10 years). Only one (8%) of the 13 patients infected with Staphylococcus aureus was successfully treated, compared with 10 (56%) of 18 patients with either Staphylococcus epidermidis or a streptococcal species. The difference between these groups is statistically significant (P=.007). The high failure rate of debridement and component retention suggests that immediate component removal should be considered in the presence of acute S. aureus infection in total knee arthroplasty.

Entities:  

Mesh:

Year:  2003        PMID: 14560406     DOI: 10.1016/s0883-5403(03)00288-2

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  38 in total

1.  Outcomes of revision total knee arthroplasty after methicillin-resistant Staphylococcus aureus infection.

Authors:  Dann J Laudermilch; Catherine J Fedorka; Alma Heyl; Nalini Rao; Richard L McGough
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

2.  Assessing the gold standard: a review of 253 two-stage revisions for infected TKA.

Authors:  Tahir Mahmud; Matthew C Lyons; Douglas D Naudie; Steven J Macdonald; Richard W McCalden
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

3.  Failure of irrigation and débridement for early postoperative periprosthetic infection.

Authors:  Thomas K Fehring; Susan M Odum; Keith R Berend; William A Jiranek; Javad Parvizi; Kevin J Bozic; Craig J Della Valle; Terence J Gioe
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

4.  Irrigation and débridement and prosthesis retention for treating acute periprosthetic infections.

Authors:  Jonathan P Van Kleunen; Denise Knox; Jonathan P Garino; Gwo-Chin Lee
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

5.  Culture-negative periprosthetic joint infection does not preclude infection control.

Authors:  Ronald Huang; Chi-Chien Hu; Bahar Adeli; Javad Mortazavi; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

Review 6.  Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts.

Authors:  Jesse Wp Kuiper; Robin Tjeenk Willink; Dirk Jan F Moojen; Michel Pj van den Bekerom; Sascha Colen
Journal:  World J Orthop       Date:  2014-11-18

7.  Treatment solutions are unclear for perimegaprosthetic infections.

Authors:  Lisa B Ercolano; Tyson Christensen; Richard McGough; Kurt Weiss
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

Review 8.  Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

9.  Direct exchange endoprosthetic reconstruction with tumour prosthesis for periprosthetic knee infection associated with segmental bone defects.

Authors:  Manjunath Ramappa; Ian McMurtry; Andrew Port
Journal:  Strategies Trauma Limb Reconstr       Date:  2010-01-12

10.  Treatment of knee prosthesis infections: evaluation of 15 patients over a 5-year period.

Authors:  Katrin Kösters; Reinout van Crevel; Patrick D J Sturm; B Willem Schreurs; Maarten C de Waal Malefijt; Albert van Kampen; Bart Jan Kullberg
Journal:  Int Orthop       Date:  2008-08-15       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.